Clinical trials: BK Nephropathy
- Condition BK Nephropathy
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
BK Virus Nephropathy
Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
BK virus (BKV) is a member of the polyomavirus family with a prevalence of up to 90% in the general population. In immunocompromized individuals, such as kidney transplant recipients (KTRs) who receive immunosuppressant therapy…
- Trial name
- SAFE KIDNEY I (NCT05358106)
- Testing
- AntiBKV
- Where
- Australia
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Memo Therapeutics AG